Congenital and acquired infections of the central nervous system (CNS) pose a significant threat to the developing brain, even in the face of appropriate medical treatment. During the past five years, a number of reports have described the ultrasound features of intracranial infection, including echogenic sulci, extra-axial fluid collections, ventricular enlargement, calcifications, abnormal parenchymal echogenicity, abscess formation, cystic degeneration of the brain parenchyma, intraventricular echogenicity, ventricular septations and irregularity and prominence of the ventricular walls. These features permit ultrasound diagnosis of intracranial infection and help to guide decisions affecting patient management.
The feasibility of in vitro activation of lymphocytes from the draining lymph nodes (DLN) of breast cancer patients was examined. Lymphocytes isolated from 48 DLN from 12 patients were examined for their proliferative responses to rIL-2, autologous tumor cells, or rIL-2 plus tumor cells. Three general patterns of cellular responses were observed. Cells from some DLN (17%) were unresponsive to any stimuli. Lymphocytes from 52% of the DLN responded moderately to rIL-2 alone. The combination of rIL-2 and tumor antigen had a synergistic effect on the proliferation of cells from 31% of the DLN assayed. Phorbol dibutyrate and ionomycin plus rIL-2 stimulated expansion of DLN lymphocytes by up to 850-fold after 35 days. These expanded cell populations, as well as those stimulated with antigen plus rIL-2, were predominantly CD3+ and CD16- cells, varying in proportions of CD4+ and CD8+ subsets. Both populations were cytotoxic against autologous tumor, MCF-7, and K562 target cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.